...
首页> 外文期刊>Journal of Neuropathology and Experimental Neurology: Official Journal of the American Association of Neuropathologists, Inc >Neuregulin 1 enhances cell adhesion molecule L1 expression in human glioma cells and promotes their migration as a function of malignancy
【24h】

Neuregulin 1 enhances cell adhesion molecule L1 expression in human glioma cells and promotes their migration as a function of malignancy

机译:神经调节蛋白1增强人胶质瘤细胞中细胞粘附分子L1的表达,并促进其作为恶性肿瘤的迁移

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Similar functions of L1, a cell adhesion molecule, and the cytokine neuregulin 1 (Nrg1) have been suggested in tumorigenesis and the promotion of metastasis. We studied the relationships of Nrg1 and L1 expression in human gliomas. Using immunofluorescence staining on a human glioma tissue microarray, we found a positive correlation between levels of L1 and Nrg1?? or Nrg1?? expression; expression tended to increase with increasing WHO (World Health Organization) tumor grade. L1 was also found to colocalize with either Nrg1 isoform. In cultures of U87-MG human glioblastoma and human U251 and SHG-44 glioma cells, the base levels of full-length L1 expression were increased by the 2 Nrg1 molecules in the nanomolar range, and Nrg1 siRNA downregulated full-length L1 expression in these tumor cell lines. U87-MG cells treated with either Nrg1 isoform also showed enhanced migration when compared with that treated with vehicle control. In addition, administration of either lapatinib (a dual inhibitor of both the epidermal growth factor receptor and ErbB-2) or erlotinib (an inhibitor of the epidermal growth factor receptor) in combination with either Nrg1?? or Nrg1?? inhibited the L1 expression elicited by these cytokines in U87-MG cells. Together, our data suggest that Nrg1 regulates L1 expression in gliomas, and that Nrg1 may contribute to malignancy by upregulating the L1 expression in glioblastoma cells, thereby enhancing their migration. ? 2013 American Association of Neuropathologists, Inc.
机译:L1,细胞粘附分子和细胞因子神经调节蛋白1(Nrg1)的相似功能已被建议用于肿瘤发生和转移的促进。我们研究了人类神经胶质瘤中Nrg1和L1表达的关系。在人胶质瘤组织微阵列上使用免疫荧光染色,我们发现L1和Nrg1β2水平之间呈正相关。还是Nrg1 ??表达;随着WHO(世界卫生组织)肿瘤等级的增加,表达水平趋于增加。还发现L1与Nrg1同工型共定位。在U87-MG人胶质母细胞瘤以及人U251和SHG-44胶质瘤细胞的培养物中,全长L1表达的碱基水平被纳摩尔范围内的2个Nrg1分子增加,而Nrg1 siRNA在这些分子中下调了全长L1表达肿瘤细胞系。与载体对照相比,用Nrg1亚型处理的U87-MG细胞也显示出增强的迁移。另外,将拉帕替尼(表皮生长因子受体和ErbB-2的双重抑制剂)或厄洛替尼(表皮生长因子受体的抑制剂)与Nrg1?2联合给药。还是Nrg1 ??抑制U87-MG细胞中这些细胞因子引起的L1表达。总之,我们的数据表明Nrg1调节神经胶质瘤中L1的表达,并且Nrg1可能通过上调胶质母细胞瘤细胞中L1的表达从而促进其迁移而促进恶性肿瘤。 ? 2013美国神经病理学家协会有限公司。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号